BIOASTER
Alexei Novoloaca has extensive experience in biostatistics and cancer research, currently serving as a Researcher in Biostatistics at BIOASTER since January 2021. Previously, Alexei held the position of Postdoctoral Researcher at the International Agency for Research on Cancer and the World Health Organization from October 2016 to December 2020, focusing on early-life exposure and epigenetic precursors of childhood cancer. Prior to that, Alexei worked as a Biostatistician at BIOASTER and completed internships involving the analysis of multi-omics data and associations between injuries in road accident victims at IFSTTAR. Alexei holds a Master's degree in Public Health from Université Claude Bernard Lyon 1, attained between 2014 and 2016.
BIOASTER
1 followers
BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures. BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries. More information on www.bioaster.org